Donor pharmacological hemodynamic support is associated with primary graft failure in human heart transplantation

Interactive Cardiovascular and Thoracic Surgery

Volumn 9, Issue 3, 2009, Pages 476-479

  Santise, Gianluca ^a   D'Ancona, Giuseppe ^a   Falletta, Calogero ^a   Pirone, Francesco ^a   Sciacca, Sergio ^a   Turrisi, Marco ^a   Biondo, Domenico ^a   Pilato, Michele ^a  

^a MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES ISMETT   (Italy)

Author keywords

Heart transplant; Primary graft failure

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; DOPAMINE;

ADULT; ARTICLE; ASSISTED CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; GRAFT FAILURE; HEART HEMODYNAMICS; HEART TRANSPLANTATION; HUMAN; INOTROPISM; MALE; MORTALITY; ORGAN DONOR; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECIPIENT;

ADULT; CARDIOTONIC AGENTS; DOPAMINE; EPINEPHRINE; EXTRACORPOREAL CIRCULATION; FEMALE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HEMODYNAMICS; HOSPITAL MORTALITY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NOREPINEPHRINE; ODDS RATIO; PRIMARY GRAFT DYSFUNCTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 69249099700     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2009.202085     Document Type: Article

References (15)

1. Wittwer T, Wahlers T. Marginal donor grafts in heart transplantation: lessons learned from 25 years of experience. Transpl Int 2008;21:113-125.
2. Taylor DO, Edwards LB, Aurora P, Christie JD, Dobbels F, Kirk R, Rahmel AO, Kucheryavaya AY, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult heart transplant report - 2008. J Heart Lung Transplant 2008;27:943-956.
3. Lima B, Rajagopal K, Petersen RP, Shah AS, Soule B, Felker GM, Rogers JG, Lodge AJ, Milano CA. Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation. Circulation 2006 4;114(1 Suppl):I27-I32. (Pubitemid 44297124)
4. Segovia J, Barcelo JM, Gomez-Bueno M, Cobo M, Garcia-Pavia P, Mirelis J, Sufrate E, Alonso-Pulpon L. A novel primary graft failure risk score in heart transplantation. J Heart Lung Transplantation 2009;28(2 Suppl):157-158.
5. Zaroff JG, Rosengard BR, Armstrong WF, Babcock WD, D'Alessandro A, Dec GW, Edwards NM, Higgins RS, Jeevanandum V, Kauffman M, Kirklin JK, Large SR, Marelli D, Peterson TS, Ring WS, Robbins RC, Russell SD, Taylor DO, Van Bakel A, Wallwork J, Young JB. Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, Va. Circulation. 2002 Aug 13;106:836-841.
6. Silva JA, Chamorro C, Romera MA. Employment of high doses of catecholamines in heart donors is not associated with development of early graft failure in the recipient. Intens Care Med 2002;28(suppl):S66.
7. Stoica SC, Satchithananda DK, White PA, Parameshwar J, Redington AN, Large SR. Noradrenaline use in the human donor and relationship with load-independent right ventricular contractility. Transplantation 2004;78:1193-1197. (Pubitemid 39426439)
8. Karamlou T, Shen I, Slater M, Crispell K, Chan B, Ravichandran P. Decreased recipient survival following orthotopic heart transplantation with use of hearts from donors with projectile brain injury. J Heart Lung Transplant 2005;24:29-33. (Pubitemid 40093988)
9. Ganesh JS, Rogers CA, Banner NR, Bonser RS. Donor cause of death and medium-term survival after heart transplantation: a United Kingdom national study. J Thorac Cardiovasc Surg 2005;129:1153-1159.
10. Cohen O, De La Zerda DJ, Beygui R, Hekmat D, Laks H. Donor brain death mechanisms and outcomes after heart transplantation. Transplant Proc 2007;39:2964-2969. (Pubitemid 350251472)
11. Tsai FC, Marelli D, Bresson J, Gjertson D, Kermani R, Patel J, Kobashigawa JA, Laks H, UCLA Heart Transplant Group. Use of hearts transplanted from donors with atraumatic intracranial bleeds. J Heart Lung Transplant 2002;21:623-628.
12. Cooper DK, Novitzky D, Wicomb WN. The pathophysiological effects of brain death on potential donor organs, with particular reference to the heart. Ann R Coll Surg Engl 1989;71:261-266. (Pubitemid 19184474)
13. Shivalkar B, Van Loon J, Wieland W, Tjandra-Maga TB, Borgers M, Plets C, Flameng W. Variable effects of explosive or gradual increase of intracranial pressure on myocardial structure and function. Circulation 1993;87:230-239. (Pubitemid 23019354)
14. Van Loon J, Shivalkar B, Plets C, Goffin J, Tjandra-Maga TB, Flameng W. Catecholamine response to a gradual increase of intracranial pressure. J Neurosurg 1993;79:705-709. (Pubitemid 23320888)
15. Powner DJ, Hendrich A, Nyhuis A, Strate R. Changes in serum catecholamine levels in patients who are brain dead. J Heart Lung Transplant 1992;11:1046-1053. (Pubitemid 23014561)